Activity_of_intrapleural_recombinant_gamma-interferon_in_malignant_mesothelioma._Twenty-two_consecutive_patients_with_malignant_diffuse_pleural_mesothelioma_were_treated_with_recombinant_gamma-interferon_by_the_intrapleural_route._Diagnosis_was_made_by_thoracoscopic_examination_and_all_cases_were_confirmed_by_the_French_Mesothelioma_Panel_of_Pathologist._Patients_were_staged_based_on_thoracoscopic_examination_and_computed_tomography_(CT)_scan:_12_patients_were_classified_as_Stage_I_and_10_were_Stage_II._A_solution_of_gamma-interferon_(40_X_106_U)_was_infused_twice_a_week_over_2_months._Every_patient_experienced_fever._One_patient_had_a_Grade_2_leukopenia_and_one_patient_suffered_from_pleural_empyema._Response_evaluation_was_based_on_the_following:_(1)_CT_scan_performed_2_weeks_after_treatment_ended,_and_(2)_repeat_thoracoscopic_examination_with_histopathologic_verification_in_nine_patients_who_had_demonstrated_a_stabilization_or_a_regression_of_the_disease_on_CT_scan._From_the_original_group,_19_patients_could_be_evaluated._Four_complete_thoracoscopic_histopathologic_responses_and_one_partial_response_were_observed_in_Stage_I_patients_(56%)._One_partial_response_was_observed_in_Stage_II_patients.